About Milla
Milla Pharmaceuticals is engaged in the development, licensing / acquisition and
commercialization of generic prescription drugs for the U.S. market focused
on niche injectable and solution products for hospitals and clinics.
Our goal is to deliver high quality medicines; via a world-class supply chain,
at affordable prices by leveraging global partnerships with FDA-approved manufacturing facilities from
around the world.
We are excited to partner with high-quality pharmaceutical developers and manufacturers that enjoy a collaborative relationship and value our expertise in product selection, market analysis, R&D, regulatory, quality and operations.
Is a Belgian group of pharmaceutical companies with headquarters in Anderlecht (Belgium) and offices in Ireland and the United States. Employing in total over 150 employees, the Group distributes a wide range of pharmaceutical products to pharmacies, wholesalers, hospitals and retirement homes.
At the same time, Alter Pharma is a global player on the generics market, with around 15 molecules on the European and US markets and a fully stocked pipeline of niche, complex and added value products.
For more information visit alterpharmagroup.be
